Initial clinical evaluation of PET-based ion beam therapy monitoring under consideration of organ motion

被引:8
作者
Kurz, Christopher [1 ,2 ]
Bauer, Julia [1 ,2 ]
Unholtz, Daniel [1 ,2 ]
Richter, Daniel [3 ,4 ]
Herfarth, Klaus [1 ,2 ]
Debus, Juergen [1 ,2 ]
Parodi, Katia [1 ,2 ,5 ]
机构
[1] Univ Heidelberg Hosp, Heidelberg Ion Beam Therapy Ctr, D-69120 Heidelberg, Germany
[2] Univ Heidelberg Hosp, Dept Radiat Oncol, D-69120 Heidelberg, Germany
[3] GSI Helmholtzzentrum Schwerionenforsch, D-64291 Darmstadt, Germany
[4] Univ Klinikum Erlangen, Strahlenklin, D-91054 Erlangen, Germany
[5] Univ Munich, Dept Med Phys, D-85748 Munich, Germany
关键词
ion beam therapy; treatment monitoring; PET; organ motion; POSITRON-EMISSION-TOMOGRAPHY; IN-BEAM; TREATMENT VERIFICATION; RANGE VERIFICATION; PROTON; IMPLEMENTATION; RADIOTHERAPY; PATIENT; ROOM; RECONSTRUCTION;
D O I
10.1118/1.4940356
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: Intrafractional organ motion imposes considerable challenges to scanned ion beam therapy and demands for a thorough verification of the applied treatment. At the Heidelberg Ion-Beam Therapy Center (HIT), the scanned ion beam delivery is verified by means of postirradiation positron emission -tomography (PET) imaging. This work presents a first clinical evaluation of PET-based treatment monitoring in ion beam therapy under consideration of target motion. Methods: Three patients with mobile liver lesions underwent scanned carbon ion irradiation at HIT and postirradiation PET/CT (x-ray-computed-tomography) imaging with a commercial scanner. Respiratory motion was recorded during irradiation and subsequent image acquisition. This enabled a time-resolved (4D) calculation of the expected irradiation-induced activity pattern and, for one patient where an additional 4D CT was acquired at the PET/CT scanner after treatment, a motion compensated PET image reconstruction. For the other patients, PET data were reconstructed statically. To verify the treatment, calculated prediction and reconstructed measurement were compared with a focus on the ion beam range. Results: Results in the current three patients suggest that for motion amplitudes in the order of 2 mm there is no benefit from incorporating respiratory motion information into PET-based treatment monitoring. For a target motion in the order of 10 mm, motion-related effects become more severe and a time-resolved modeling of the expected activity distribution can lead to an improved data interpretation if a sufficient number of true coincidences is detected. Benefits from motion-compensated PET image reconstruction could not be shown conclusively at the current stage. Conclusions: The feasibility of clinical PET-based treatment verification under consideration of organ motion has been shown for the first time. Improvements in noise-robust 4D PET image reconstruction are deemed necessary to enhance the clinical potential. (C) 2016 American Association of Physicists in Medicine.
引用
收藏
页码:975 / 982
页数:8
相关论文
共 38 条
[1]   Implementation and initial clinical experience of offline PET/CT-based verification of scanned carbon ion treatment [J].
Bauer, Julia ;
Unholtz, Daniel ;
Sommerer, Florian ;
Kurz, Christopher ;
Haberer, Thomas ;
Herfarth, Klaus ;
Welzel, Thomas ;
Combs, Stephanie E. ;
Debus, Juergen ;
Parodi, Katia .
RADIOTHERAPY AND ONCOLOGY, 2013, 107 (02) :218-226
[2]   Motion in radiotherapy: particle therapy [J].
Bert, C. ;
Durante, M. .
PHYSICS IN MEDICINE AND BIOLOGY, 2011, 56 (16) :R113-R114
[3]   Quantification of interplay effects of scanned particle beams and moving targets [J].
Bert, Christoph ;
Groezinger, Sven O. ;
Rietzel, Eike .
PHYSICS IN MEDICINE AND BIOLOGY, 2008, 53 (09) :2253-2265
[4]   The FLUKA Code: Developments and Challenges for High Energy and Medical Applications [J].
Boehlen, T. T. ;
Cerutti, F. ;
Chin, M. P. W. ;
Fosso, A. ;
Ferrari, A. ;
Ortega, P. G. ;
Mairani, A. ;
Sala, P. R. ;
Smirnov, G. ;
Vlachoudisl, V. .
NUCLEAR DATA SHEETS, 2014, 120 :211-214
[5]  
Casey M.E., 2007, POINT SPREAD FUNCTIO
[6]  
Casey M E., 2008, Improving PET With HD*PET + Time of Flight
[7]   Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: The PROMETHEUS-01 trial [J].
Combs, Stephanie E. ;
Habermehl, Daniel ;
Ganten, Tom ;
Schmidt, Jan ;
Edler, Lutz ;
Burkholder, Iris ;
Jaekel, Oliver ;
Haberer, Thomas ;
Debus, Juergen .
BMC CANCER, 2011, 11
[8]   Robustness of target dose coverage to motion uncertainties for scanned carbon ion beam tracking therapy of moving tumors [J].
Eley, John Gordon ;
Newhauser, Wayne David ;
Richter, Daniel ;
Luechtenborg, Robert ;
Saito, Nami ;
Bert, Christoph .
PHYSICS IN MEDICINE AND BIOLOGY, 2015, 60 (04) :1717-1740
[9]   Charged hadron tumour therapy monitoring by means of PET [J].
Enghardt, W ;
Crespo, P ;
Fiedler, F ;
Hinz, R ;
Parodi, K ;
Pawelke, J ;
Pönisch, F .
NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 2004, 525 (1-2) :284-288
[10]  
Ferrari A., 2005, CERN200510, DOI [DOI 10.2172/877507, 10.5170/CERN-2005-010, DOI 10.5170/CERN-2005-010]